January 18, 2018 / 6:16 AM / a month ago

BRIEF-MDxHealth ‍Develops Blood Test For Prostate Cancer Patients​

Jan 18 (Reuters) - MDXHEALTH SA:

* ‍DEVELOPS BLOOD TEST TO GUIDE PRECISION-TREATMENT OF CASTRATION-RESISTANT PROSTATE CANCER PATIENTS​

* STUDY DEMONSTRATES TEST CAN ADD PROGNOSTIC INFORMATION ON OVERALL SURVIVAL

* ‍EARLIER ASSESSMENT OF TREATMENT RESPONSE CAN HELP IDENTIFY RESISTANCE SOONER​

* OVER 233,000 CRPC PATIENTS UNDER TREATMENT GLOBALLY EACH YEAR Source text for Eikon: Further company coverage: (Gdynia Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below